US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,912.72

+10.760.57%

Number of Gainers:68

Number of Losers:27

Number of Flat:1

PE:- -

High:1,918.65

Open:1,901.96

Low:1,875.77

Close:1,901.96

Loading ...

Analysts Offer Insights on Financial Companies: Marketaxess Holdings (MKTX) and JPMorgan Chase & Co. (JPM)

Bristol Myers Gets Expanded Europe OK of Opdivo/Yervoy Combo in Liver Cancer

Daiwa Adjusts Price Target on Target to $120 From $130, Maintains Neutral Rating

MT Newswires Live

BRIEF-Bristol Myers Squibb Receives European Commission Approval For Opdivo® (Nivolumab) Plus Yervoy® (Ipilimumab)

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS

BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic Fibrosis

UK's Mhra Says Triple Combination Medicine Deutivacaftor/Tezacaftor/Vanzacaftor Approved for Cystic Fibrosis

THOMSON REUTERS

The ‘economic blackout’ movement now wants you to boycott Amazon, starting today

Kroger Co : Citigroup Raises Target Price to $65 From $61

THOMSON REUTERS

Apple Receives Local Content Certificates for 20 Products in Indonesia

MT Newswires Live

AI Chips Update - Unlocking AI: Qualcomm Powers Efficient Inference Cloud Solutions

Simply Wall St.

Union Pacific initiated with a Buy at Deutsche Bank

Under The Bonnet, Colgate-Palmolive's (NYSE:CL) Returns Look Impressive

Simply Wall St.

38% of Berkshire Hathaway's Portfolio Is Invested in These 3 Unstoppable Dividend Stocks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4532/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4532"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1912.7213,"timestamp":1741381199999,"preClose":1901.9585,"halted":0,"volume":1124904543,"delay":0,"changeRate":0.005659,"change":10.762817,"pbRate":8.603584,"amount":135119673650.74295,"amplitude":0.022546,"prevYearClose":2026.1482,"fiveDayClose":1965.7411,"twentyDayClose":2044.8126,"turnoverRate":0.008743,"marketCap":21363470568128,"floatMarketCap":19968293404480,"peRate":31.475371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1918.6505,"amplitude":0.022546,"preClose":1901.9585,"low":1875.7682,"pbRate":"8.603584","latestPrice":1912.7213,"volume":1124904543,"delay":0,"open":1901.9614,"prevYearClose":2026.1482,"prevWeekClose":1965.7411,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1965.7411,"twentyDayClose":2044.8126,"sixtyDayClose":2084.0764,"secType":"PLATE","market":"US","turnoverRate":0.008743,"peRate":31.475371,"marketCap":21363470568128,"floatMarketCap":19968293404480,"timestamp":1741381199999,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":68,"down":27,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517348451","title":"Analysts Offer Insights on Financial Companies: Marketaxess Holdings (MKTX) and JPMorgan Chase & Co. (JPM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517348451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517348451?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:13","pubTimestamp":1741349581,"startTime":"0","endTime":"0","summary":"Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Marketaxess Holdings (MKTX – Research Report) and J...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-financial-companies-marketaxess-holdings-mktx-and-jpmorgan-chase-co-jpm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-financial-companies-marketaxess-holdings-mktx-and-jpmorgan-chase-co-jpm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0943347566.SGD","LU2552382058.USD","IE00BLSP4239.USD","LU1084165304.USD","JPMLL","LU1670628061.USD","LU0048584097.USD","IE00BZ1G4Q59.USD","LU0211327993.USD","LU2430703251.USD","IE00BLSP4452.SGD","IE00BKDWB100.SGD","LU0882574139.USD","LU1670627923.USD","LU1496350502.SGD","LU0820562030.AUD","BK4585","IE0034235188.USD","LU1261432733.SGD","LU0267386448.USD","LU0256863811.USD","IE0034235303.USD","LU2213496289.HKD","BK4532","LU0320765489.SGD","IE00BYXW3230.USD","LU2237443549.SGD","MKTX","LU0203347892.USD","LU0070302665.USD","BK4207","LU0215105999.USD","LU0868494708.USD","LU0683600562.USD","BK4516","LU2357305700.SGD","IE00BBT3K403.USD","BK4550","LU1720051017.SGD","LU1974910355.USD","LU2756315664.SGD","IE00BHPRN162.USD","IE00BJLML261.HKD","LU1162221912.USD","LU2023250843.SGD","LU1629891620.HKD","LU0942090050.USD","BK4504","LU0106831901.USD","LU2505996509.AUD"],"gpt_icon":0},{"id":"2517828944","title":"Bristol Myers Gets Expanded Europe OK of Opdivo/Yervoy Combo in Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517828944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517828944?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:12","pubTimestamp":1741349520,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer.Bristol Myers on Friday said the approval covers the combination for the first-line treatment of adults with unresectable or advanced hepatocellular carcinoma.Liver cancer is the third most frequent cause of cancer death worldwide, and hepatocellular carcinoma is the most common type of liver cancer, accounting for 90% of global cases, the Princeton, N.J., biopharmaceutical company said.The Opdivo/Yervoy combination is already approved in several cancer indications worldwide. The U.S. Food and Drug Administration is reviewing the combination as a potential first-line treatment option for adults with unresectable hepatocellular carcinoma, with a target action date of April 21.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1093756325.SGD","LU1323610961.USD","LU1868836914.USD","LU2360032135.SGD","LU1093756168.USD","IE00BFXG1179.USD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU1868837136.USD","LU0882574055.USD","LU1670710661.SGD","LU1670711040.USD","LU0321505439.SGD","BK4126","BK4585","LU1291159041.SGD","LU2125154778.USD","LU0114720955.EUR","LU1585245621.USD","LU0985481810.HKD","MYE","IE00BSNM7G36.USD","BK4559","LU0306807586.USD","LU1868836591.USD","LU1032466523.USD","LU2125154935.USD","LU1571399168.USD","BMY","BK4581","BK4534","LU1670711123.USD","LU1868836757.USD","BK4007","LU1718418525.SGD","LU1989771016.USD","LU1261432733.SGD","LU1074936037.SGD","LU2133065610.SGD","IE00B2B36J28.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0868494617.USD","LU1430594728.SGD","LU0456855351.SGD","LU0225771236.USD","LU1670710588.SGD","BK4532"],"gpt_icon":0},{"id":"2517629481","title":"Daiwa Adjusts Price Target on Target to $120 From $130, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517629481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517629481?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:05","pubTimestamp":1741349111,"startTime":"0","endTime":"0","summary":"Target (TGT) has an average rating of overweight and mean price target of $135.04, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4114","LU2237443622.USD","LU0310799852.SGD","BK4155","LU1267930227.SGD","LU1244550577.SGD","BK4504","BK4585","BK4597","LU0128525689.USD","LU2237443549.SGD","LU2237443382.USD","LU0823411888.USD","LU1244550494.USD","BK4588","BK4532","LU0211327993.USD","LU2237443978.SGD","LU1267930490.SGD","LU0310800965.SGD","LU0211328371.USD","LU0052756011.USD","BK4596","LU1244550221.USD","BK4533"],"gpt_icon":0},{"id":"2517648909","title":"BRIEF-Bristol Myers Squibb Receives European Commission Approval For Opdivo® (Nivolumab) Plus Yervoy® (Ipilimumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517648909","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517648909?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:00","pubTimestamp":1741348832,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb Receives European Commission Approval For Opdivo (Nivolumab) Plus Yervoy (Ipilimumab) March 7 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB RECEIVES EUROPEA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032466523.USD","LU1093756168.USD","LU0456855351.SGD","LU1718418525.SGD","BK4559","LU0868494617.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0321505439.SGD","LU2125154935.USD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU0061475181.USD","BMY","IE0002141913.USD","LU0114720955.EUR","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4585","LU0225771236.USD","BK4534","LU0096364046.USD","LU1074936037.SGD","LU2125154778.USD","BK4532","LU1323610961.USD","LU2133065610.SGD","LU0237698245.USD","LU0985481810.HKD","LU1670711040.USD","IE0009355771.USD","LU0882574055.USD","LU1430594728.SGD","LU1868837136.USD","LU1093756325.SGD","LU1868836757.USD","LU1670710588.SGD","LU0306807586.USD","LU1571399168.USD","LU2242652126.USD","LU1670711123.USD","LU1868836591.USD","LU0306806265.USD","BK4588","BK4007","IE00BSNM7G36.USD","LU1585245621.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2517482934","title":"IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2517482934","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517482934?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:00","pubTimestamp":1741348800,"startTime":"0","endTime":"0","summary":"MATTERHORN is first global, randomized Phase III trial to demonstrate superior event-free survival with an immunotherapy combination over standard of care in this setting. IMFINZI plus chemotherapy more than doubled pathologic complete response rate in previously reported analysis of this trial in 2023. WILMINGTON, Del., March 07, 2025----Positive high-level results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI  in combination with standard-of-care FLOT  chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival . Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced  gastric and gastroesophageal j","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imfinzi-durvalumab-based-regimen-demonstrated-120000536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4156","BK4124","AZN","BK4008","BK4532","CRT","BTC","LU1829250122.USD","BK4097","HSCT","LU2417539215.USD","BK4588","BK4007","BK4500","LU2462157665.USD","FLOT","HCC","OS","LU2456880835.USD","BK4568","BK4144","LU0109394709.USD","ALK","TEN","LU0320765992.SGD","VOD","BK4006","BK4213","BK4132","LU2236285917.USD","BK4582","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517438854","title":"Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438854","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517438854?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:59","pubTimestamp":1741348740,"startTime":"0","endTime":"0","summary":"Approval based on results of Phase 3 CheckMate -9DW clinical trial demonstrating a statistically significant and clinically meaningful improvement in overall survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib. PRINCETON, N.J., March 07, 2025----Bristol Myers Squibb  today announced that the European Commission  has approved Opdivo  plus Yervoy  for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma .\"The European Commission’s approval for Opdivo plus Yervoy adds to the growing body of evidence demonstrating the value of dual immunotherapy and represents an important new treatment option that may extend survival for patients with hepatocellular carcinoma,\" said Dana Walker, M.D., M.S.C.E., vice president, Opdivo global program lead, Bristol Myers Squibb. \"This approval marks a critical milestone in our commitment to improving outcomes for patients with liver cancer. We look forward to bringing this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-european-115900243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4132","ORR","AEIS","LU1868837300.USD","CRT","LU2242646821.SGD","LU0321505868.SGD","LU1032466523.USD","LU0096364046.USD","BK4581","LU1261432733.SGD","LU0225284248.USD","LU1430594728.SGD","MYE","BK4213","IE00B19Z4B17.USD","LU1291159041.SGD","LU2125154935.USD","VOD","LU0061475181.USD","LU1670711040.USD","CRC","LU0306807586.USD","ALK","LU1868836914.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","LU0237698245.USD","BMY","IE00BSNM7G36.USD","EC","HSCT","HCC","OS","BK4532","LU0306806265.USD","BK4201","BK4097","TEN","BK4124","LU0321505439.SGD","RCC","LU1868836591.USD","LU0114720955.EUR","BK4157","LU0868494617.USD","IE00B7SZL793.SGD","LU1670710588.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2517348187","title":"Jazz Pharmaceuticals upgraded to Buy from Neutral at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2517348187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517348187?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:56","pubTimestamp":1741348582,"startTime":"0","endTime":"0","summary":"UBS upgraded Jazz Pharmaceuticals (JAZZ) to Buy from Neutral with a price target of $179, up from $145. The company’s base business strength and Zi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jazz-pharmaceuticals-upgraded-to-buy-from-neutral-at-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jazz-pharmaceuticals-upgraded-to-buy-from-neutral-at-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2357305700.SGD","ZI","BK4007","LU0823416689.USD","IE00BN0W2T93.GBP","LU0889565916.HKD","LU1861220033.SGD","LU1720051017.SGD","BK4533","BK4077","BK4532","LU1720051108.HKD","LU1861215975.USD","JAZZ","LU0320765992.SGD","IE00BN0W2V16.EUR","LU0109394709.USD","BK4585","LU1548497426.USD","IE00BN0W2W23.USD","BK4588"],"gpt_icon":0},{"id":"2517748627","title":"BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517748627","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517748627?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:39","pubTimestamp":1741347561,"startTime":"0","endTime":"0","summary":"BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic FibrosisMarch 7 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY:UK'S MHRA SAYS TRIPLE COM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IE0002141913.USD","LU2456880835.USD","IE00B19Z9Z06.USD","BK4585","LU0320765992.SGD","LU1430594728.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU2237438978.USD","LU2362541513.USD","LU2362540622.SGD","IE00B19Z3B42.SGD","LU1035775433.USD","LU0289739699.SGD","LU1093756168.USD","LU0234570918.USD","IE00B4R5TH58.HKD","LU0823416689.USD","IE00BZ9MQY76.HKD","VRTX","LU0417517546.SGD","BK4533","IE00B19Z3581.USD","BK4567","LU2462157665.USD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4588","BK4532","LU0256863811.USD","LU1585245621.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU2417539215.USD","IE00BJT1NW94.SGD","IE0002270589.USD","IE00B894F039.SGD","LU0889565916.HKD","LU0109394709.USD","LU1069344957.HKD","BK4139","LU2362541273.HKD","LU0061475181.USD"],"gpt_icon":0},{"id":"2517486604","title":"UK's Mhra Says Triple Combination Medicine Deutivacaftor/Tezacaftor/Vanzacaftor Approved for Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517486604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517486604?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:37","pubTimestamp":1741347452,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","LU0109394709.USD","LU1093756325.SGD","LU2236285917.USD","BK4533","BK4139","LU2456880835.USD","BK4567","IE0002141913.USD","LU1093756168.USD","LU2362540622.SGD","LU1069344957.HKD","LU2462157665.USD","LU2362541513.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4585","LU1585245621.USD","LU1035775433.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0058720904.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU0079474960.USD","LU2324357040.USD","BK4588","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0320765992.SGD","VRTX","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU2362541273.HKD","IE0009355771.USD","LU0417517546.SGD","LU1430594728.SGD","LU0256863811.USD","LU0889565916.HKD","BK4532"],"gpt_icon":0},{"id":"2517843034","title":"The ‘economic blackout’ movement now wants you to boycott Amazon, starting today","url":"https://stock-news.laohu8.com/highlight/detail?id=2517843034","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517843034?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:30","pubTimestamp":1741347052,"startTime":"0","endTime":"0","summary":"A grassroots movement’s call for Americans not to shop at major chains for 24 hours in an “economic blackout” last week went viral — and now, its organizer is launching a weeklong boycott against Amazon that starts Friday.John Schwarz, the 57-year-old founder of The People’s Union USA, is calling on Americans to boycott Amazon and its companies, including Zappos, Ring, Whole Foods, Twitch and Prime Video, for one week.Schwarz is leveraging the attention from the wider “economic blackout” on February 28. He told CNN in an interview last week that he hadn’t expect much traction for his post, which was viewed millions of times. Celebrities like Stephen King and Bette Midler encouraged participation, and reporters wrote and aired TV pieces about it.Still, the “economic blackout” effort is relatively uncoordinated and nebulous. Experts on consumer boycotts and corporate strategy are dubious that it will make a dent in the bottom lines of the massive companies that it targets, let alone the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2025/03/07/business/amazon-economic-blackout/index.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["LU2023250330.USD","LU1718418525.SGD","LU0345768740.USD","LU2028103732.USD","LU1934455277.USD","LU0648001328.SGD","LU2471134879.HKD","IE00BMPRXN33.USD","BK4535","SG9999017495.SGD","SGXZ31699556.SGD","USAW.SI","SG9999018857.SGD","LU1064131342.USD","LU0528227936.USD","AMZN","LU1066051225.USD","LU1119994496.HKD","LU2317271919.USD","LU0256863811.USD","LU0149725797.USD","IE00BMPRXQ63.HKD","LU0466842654.USD","LU2417539215.USD","IE0004445015.USD","LU0314104364.USD","IE00B1XK9C88.USD","LU1496350502.SGD","IE00BYQQ9H92.USD","LU0943347566.SGD","BK4532","LU0965509101.SGD","LU0308772762.SGD","LU1084165304.USD","LU2065171311.SGD","LU2247934214.USD","LU2361045086.USD","IE00B1BXHZ80.USD","LU1435385759.SGD","LU0056508442.USD","LU2275660780.HKD","LU2271345857.HKD","LU1316542783.SGD","LU2420271590.USD","LU0082616367.USD","LU1244550221.USD","BK4538","IE00B19Z9505.USD","BK4612","LU1839511570.USD"],"gpt_icon":1},{"id":"2517485556","title":"Kroger Co : Citigroup Raises Target Price to $65 From $61","url":"https://stock-news.laohu8.com/highlight/detail?id=2517485556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517485556?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:17","pubTimestamp":1741346274,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0130102774.USD","LU0312595415.SGD","LU0980610538.SGD","LU0345770993.USD","BK4585","LU0130517989.USD","LU0345770308.USD","LU1201861249.SGD","BK4533","KR","LU0302445910.USD","BK4113","LU2275660780.HKD","BK4532","LU0477156953.USD","BK4504","BK4588","LU0648001328.SGD","BK4559"],"gpt_icon":0},{"id":"2517485581","title":"Apple Receives Local Content Certificates for 20 Products in Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2517485581","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517485581?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:17","pubTimestamp":1741346261,"startTime":"0","endTime":"0","summary":"Apple (AAPL) has received local content certificates in Indonesia for 20 products, including the iPhone 16, multiple news outlets reported Friday, citing the country's industry ministry spokesperson.I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"7186b3d0d2d5623071139b3000997470","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1206712785.SGD","LU2471134796.USD","HK0000320264.USD","IE0005OL40V9.USD","LU1116320901.HKD","LU1571399168.USD","LU0466842654.USD","LU2054465674.USD","LU0985320562.USD","LU0719512351.SGD","LU0203201768.USD","LU1935042488.USD","LU0348723411.USD","LU2756315318.SGD","LU2023250330.USD","IE00B3SWFQ91.USD","IE00B5949003.HKD","IE00B7KXQ091.USD","LU0545039389.USD","LU1291159041.SGD","AAPL","LU2125154778.USD","LU2430703095.HKD","LU0203202063.USD","LU1582986359.USD","LU0215105999.USD","MACW.SI","LU2462157665.USD","BK4532","BK4501","LU0149725797.USD","LU1935043536.SGD","LU0823434740.USD","IE000W1ABFV2.USD","LU0456855351.SGD","LU0784385840.USD","LU0642271901.SGD","LU1366192091.USD","LU2247934214.USD","LU0354030511.USD","IE00B4YYXB79.USD","LU2236285917.USD","LU2471134523.USD","LU2360032135.SGD","SG9999015986.USD","IE000KEQY171.SGD","LU2213496289.HKD","LU0689472784.USD","LU1642822529.SGD","LU1852331112.SGD"],"gpt_icon":1},{"id":"2517867124","title":"AI Chips Update - Unlocking AI: Qualcomm Powers Efficient Inference Cloud Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2517867124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517867124?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:07","pubTimestamp":1741345661,"startTime":"0","endTime":"0","summary":"Cirrascale Cloud Services has announced the launch of its Inference Cloud, powered by the Qualcomm AI Inference Suite, to facilitate the streamlined deployment of AI models and applications with just a single click. This new cloud offering aims to meet the growing demand for generative AI by enabling efficient and scalable AI solutions across industries. Built on the Qualcomm Cloud AI 100 Ultra, the Inference Cloud provides customers with cost-effective access to a wide range of pre-configured AI models and applications, supporting key AI-driven use cases. By allowing businesses to pay only for their AI model usage, this service simplifies integration and broadens access to advanced AI capabilities.QUALCOMM last closed at $156.04 down 1.5%, hovering around its 52-week low.As a follow-up, take a look at our Market Insights article, \"DeepSeek and Trump’s EOs: The Winners and Losers,\" where we explored the significant impact of DeepSeek's R1 model on the AI chip market, highlighting both ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ai-chips-unlocking-ai-qualcomm-110741405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4575","BK4579","LU1261432733.SGD","LU2023250504.SGD","BK4554","SG9999015978.USD","LU1046421795.USD","IE00BVYPNQ40.USD","IE00BSNM7G36.USD","LU1823568750.SGD","BK4585","LU2247934214.USD","BK4512","BK4515","BK4573","BK4561","IE00BVYPNP33.GBP","BK4612","LU1974910355.USD","SG9999015986.USD","NVDA","LU0061475181.USD","AMD","SG9999001424.SGD","LU0942090050.USD","SG9999015945.SGD","LU0868494708.USD","BK4534","INTC","LU1084165304.USD","LU2106854487.HKD","LU1035775433.USD","SG9999015952.SGD","GB00BDT5M118.USD","LU0868494617.USD","LU1917777945.USD","BK4141","BK4527","LU0079474960.USD","IE00BGHQDM52.EUR","BK4604","BK4605","LU1119994496.HKD","BK4532","BK4581","LU1069344957.HKD","QCOM","BK4588"],"gpt_icon":1},{"id":"2517485168","title":"Union Pacific initiated with a Buy at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2517485168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517485168?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:01","pubTimestamp":1741345301,"startTime":"0","endTime":"0","summary":"Deutsche Bank initiated coverage of Union Pacific (UNP) with a Buy rating and $295 price target Published first on TheFly – the ultimate source for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/union-pacific-initiated-with-a-buy-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/union-pacific-initiated-with-a-buy-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BBT3K403.USD","GB00BDT5M118.USD","BK4534","LU0949170772.SGD","LU0312595415.SGD","LU0943347566.SGD","LU0742534661.SGD","BK4016","IE00B29SXL02.USD","LU0820561909.HKD","LU0661504455.SGD","LU0689472784.USD","IE00BMG7P926.USD","LU1003077747.HKD","BK4552","BK4588","LU1861219969.SGD","LU0553294199.USD","LU1894683348.USD","IE00BMG7P819.SGD","UNP","IE00B29SXK94.USD","IE00BMG7P702.HKD","BK4585","LU0251142724.SGD","IE00BD4GTV84.USD","LU0738911758.USD","LU1978683503.SGD","IE00BD4GTT62.SGD","LU1303367103.USD","LU1861214812.USD","LU0251131958.USD","IE00BMG7P587.USD","LU2756315664.SGD","LU0048573561.USD","LU0820562030.AUD","LU2360107325.USD","BK4532","BK4118","DB","LU0124384867.USD","LU0354030438.USD","LU2098885051.SGD","LU0302445910.USD","LU0868494617.USD","LU1551013425.SGD","LU2463526074.USD","LU0820561818.USD","IE00BMG7P694.USD","BK4581"],"gpt_icon":0},{"id":"2517864014","title":"Under The Bonnet, Colgate-Palmolive's (NYSE:CL) Returns Look Impressive","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517864014?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:00","pubTimestamp":1741345241,"startTime":"0","endTime":"0","summary":"If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for?Amongst other things, we'll want to see two things; firstly, a growing return on capital employed  and secondly, an expansion in the company's amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Speaking of which, we noticed some great changes in Colgate-Palmolive's  returns on capital, so let's have a look.If you haven't worked with ROCE before, it measures the 'return'  a company generates from capital employed in its business. The formula for this calculation on Colgate-Palmolive is:. Return on Capital Employed = Earnings Before Interest and Tax  ÷ . Thus, Colgate-Palmolive has an ROCE of 41%.  In absolute terms that's a great return and it's even better than the Household Products industry average of 18%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/under-bonnet-colgate-palmolives-nyse-110041067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2108987350.USD","CL","LU1675838814.USD","LU1430594728.SGD","BK4504","LU2125154935.USD","NYSE","LU0266013472.USD","LU1236620834.HKD","LU2125154778.USD","LU1150488218.USD","LU1599440770.SGD","BK4533","LU2360032135.SGD","LU1236620750.USD","LU1941712348.USD","BK4588","LU2463526074.USD","EBIT","LU1150488135.SGD","BK4532","LU0323591593.USD","LU1585245621.USD","SG9999001440.SGD","BK4018","LU0731783394.SGD","LU0985320562.USD","LU1571399168.USD","BK4585","LU1941712264.USD"],"gpt_icon":0},{"id":"2517489138","title":"38% of Berkshire Hathaway's Portfolio Is Invested in These 3 Unstoppable Dividend Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2517489138","media":"Motley Fool","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517489138?lang=en_us&edition=fundamental","pubTime":"2025-03-07 18:45","pubTimestamp":1741344300,"startTime":"0","endTime":"0","summary":"Apple, Coca-Cola, and Visa are industry leaders with strong moats.All three companies have solid dividend growth track records.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/07/38-of-berkshire-hathaway-portfolio-is-invested-in/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1935042991.SGD","LU1852331112.SGD","LU2357305700.SGD","KO","IE0004086264.USD","LU0289961442.SGD","LU1815336760.USD","IE0005OL40V9.USD","BRK.A","IE0009356076.USD","IE000W1ABFV2.USD","LU1670711040.USD","LU0957791311.USD","LU1989764664.SGD","V","SG9999003800.SGD","AAPL","LU2236285917.USD","LU0251142724.SGD","LU0466842654.USD","IE00BJTD4N35.SGD","LU1236620834.HKD","BK4588","LU2237443382.USD","LU0689626769.HKD","SG9999015945.SGD","LU1228905540.USD","MACW.SI","LU2097344431.USD","SG9999015986.USD","LU1032955483.USD","GB00B4LPDJ14.GBP","LU1582987597.SGD","LU1814569148.SGD","IE00B3S45H60.SGD","LU0187121727.USD","BK4585","BK4532","SGXZ81514606.USD","LU0784385840.USD","LU1778281490.HKD","LU1244550577.SGD","SG9999018857.SGD","LU0130102774.USD","LU0823421416.USD","SG9999014914.USD","LU1261432733.SGD","LU1116320737.USD","LU2089284900.SGD"],"gpt_icon":1}],"pageSize":16,"totalPage":127,"pageCount":11,"totalSize":2027}]}}